Sponsor or institution
Clinical trials and research at Ihp Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $5.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Glycan-based at-home treatment to shorten painful VOEs in sickle cell disease
A new at-home therapy called IHP-102 aims to modify the disease’s pain crises in adults with sickle cell disease.
-
At-home glycan medicine to stop sickle cell pain crises
A new at-home glycan medicine that blocks P-selectin and complement to stop or shorten painful vaso-occlusive crises for adults with sickle cell disease.
-
New treatment to help manage pain crises in sickle cell disease at home
This study is testing a new treatment called IHP-100 to help people with sickle cell disease manage their pain at home, making it easier for them to handle painful episodes without always needing to go to the hospital.
-
A new treatment to help manage pain crises in sickle cell disease at home
This study is testing a new treatment called IHP-102 for people with sickle cell disease who have painful episodes, aiming to help them manage their pain better at home without relying so much on opioids.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.